Literature DB >> 9671389

Functional dissection of Bfl-1, a Bcl-2 homolog: anti-apoptosis, oncogene-cooperation and cell proliferation activities.

C D'Sa-Eipper1, G Chinnadurai.   

Abstract

The human Bfl-1 gene codes for a 175-amino acid BCL-2 family protein that has an anti-apoptosis activity and is overexpressed in certain human epithelial and hematopoietic malignancies. Bfl-1 efficiently suppresses apoptosis induced by the p53 tumor suppressor protein and cooperates with a dominant nuclear oncogene, E1A, in transformation of primary epithelial cells in vitro. Unlike other BCL-2 family proteins, expression of BFL-1 permits limited cell proliferation over an extended period of time when cells are induced to undergo apoptosis. We have carried out mutational analysis to dissect the various activities encoded by Bfl-1 and to determine the sequence requirements for these activities. BFL-1 shares four conserved domains, BH1, BH2, BH3 and BH4 with other BCL-2 family proteins. Mutations within BH1, BH2 and BH4 domains abolish or greatly attenuate the anti-apoptotic, oncogene cooperation and proliferation facilitating activities of BFL-1. In contrast, a mutation within the BH3 domain (which is essential for the activity of pro-apoptotic members of the BCL-2 family) does not significantly affect the BFL-1 functions. Although BFL-1 does not contain a well-defined C-terminal transmembrane domain, deletion of the C-terminal 24 amino acid region (corresponding to the transmembrane domain of other BCL-2 family proteins) partially reduces the various activities of BFL-1. All the mutants defective in the anti-apoptosis activity are also defective in the oncogene cooperation activity suggesting that these two activities may be linked. A unique feature of BFL-1 is the presence of a Gln-rich N-terminal region that overlaps with the BH4 domain. The Gln residues appear to be essential for the proliferation permitting activity of BFL-1. Since mutations of the Gln residues located within the BH4 domain appear to confer an extended cell survival activity in the absence of cell proliferation, our results suggest that BFL-1 communicates with both cell proliferation and apoptosis machineries and suggest a link between these two activities.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9671389     DOI: 10.1038/sj.onc.1201851

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  19 in total

1.  NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes.

Authors:  H H Lee; H Dadgostar; Q Cheng; J Shu; G Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

2.  NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis.

Authors:  C Y Wang; D C Guttridge; M W Mayo; A S Baldwin
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

3.  To live or die: a critical decision for the lung.

Authors:  G R Scott Budinger; Jacob I Sznajder
Journal:  J Clin Invest       Date:  2005-04       Impact factor: 14.808

4.  Potential targets of FOXL2, a transcription factor involved in craniofacial and follicular development, identified by transcriptomics.

Authors:  Frank Batista; Daniel Vaiman; Jean Dausset; Marc Fellous; Reiner A Veitia
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

5.  C-terminal residues regulate localization and function of the antiapoptotic protein Bfl-1.

Authors:  Gaelle Brien; Anne-Laure Debaud; Xavier Robert; Lisa Oliver; Marie-Claude Trescol-Biemont; Nicolas Cauquil; Olivier Geneste; Nushin Aghajari; Francois M Vallette; Richard Haser; Nathalie Bonnefoy-Berard
Journal:  J Biol Chem       Date:  2009-09-15       Impact factor: 5.157

6.  Epstein-Barr virus nuclear antigen 2 trans-activates the cellular antiapoptotic bfl-1 gene by a CBF1/RBPJ kappa-dependent pathway.

Authors:  Pamela M Pegman; Sinéad M Smith; Brendan N D'Souza; Sinéad T Loughran; Sabine Maier; Bettina Kempkes; Paul A Cahill; Matthew J Simmons; Céline Gélinas; Dermot Walls
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

7.  Meningococcal porin PorB prevents cellular apoptosis in a toll-like receptor 2- and NF-kappaB-independent manner.

Authors:  Paola Massari; Jay Gunawardana; Xiuping Liu; Lee M Wetzler
Journal:  Infect Immun       Date:  2009-12-22       Impact factor: 3.441

8.  The Bcl-2 family member Bfl-1/A1 is strongly repressed in normal and malignant plasma cells but is a potent anti-apoptotic factor for myeloma cells.

Authors:  Karin Tarte; Michel Jourdan; Jean Luc Veyrune; Ingolf Berberich; Geneviève Fiol; Nicole Redal; John Shaughnessy; Bernard Klein
Journal:  Br J Haematol       Date:  2004-05       Impact factor: 6.998

9.  The C-terminal domain of A1/Bfl-1 regulates its anti-inflammatory function in human endothelial cells.

Authors:  Renata P Guedes; Eduardo Rocha; Jerome Mahiou; Herwig P Moll; Maria B Arvelo; Janis M Taube; Clayton R Peterson; Elzbieta Kaczmarek; Christopher R Longo; Cleide G da Silva; Christiane Ferran
Journal:  Biochim Biophys Acta       Date:  2013-03-13

10.  Bfl-1/A1 functions, similar to Mcl-1, as a selective tBid and Bak antagonist.

Authors:  M J Simmons; G Fan; W-X Zong; K Degenhardt; E White; C Gélinas
Journal:  Oncogene       Date:  2007-09-03       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.